« Zurück
Home /
L-Ascorbic acid

L-Ascorbic acid

ArtNr	HY-B0166-500mg
Hersteller	MedChem Express
CAS-Nr.	50-81-7
Menge	500 mg
Quantity options	10 mM/1 mL 1 g 500 mg
Kategorie	Food Safety Vitamines Inhibitors & Compound Libraries Small Molecules Acid Determination
Typ	Inhibitors
Specific against	other
Purity	99.99
Formula	C6H8O6
Citations	[1]Sebastian J Padayatty, et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003 Feb;22(1):18-35. [2]Michael T Nelson, et al. Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate. J Neurosci. 2007 Nov 14;27(46):12577-83. [3]Aleksander Hinek, et al. Sodium L-ascorbate enhances elastic fibers deposition by fibroblasts from normal and pathologic human skin. J Dermatol Sci. 2014 Sep;75(3):173-82. [4]Sungrae Cho, et al. Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression. Sci Rep. 2018 Jul 27;8(1):11372. [5]Satyanarayana Sreemantula, et al. Influence of antioxidant (L- ascorbic acid) on tolbutamide induced hypoglycaemia/antihyperglycaemia in normal and diabetic rats. BMC Endocr Disord. 2005 Mar 3;5(1):2. Anim Biotechnol. 2024 Nov;35(1):2404043. Antioxid Redox Signal. 2020 Dec 10;33(17):1191-1208. Antioxidants (Basel). 2024 May 27. Biochem Biophys Res Commun. 2024 Mar 15, 149770. Biomaterials. 2024 Aug 15:313:122756. Biomed Pharmacother. September 2022, 113558. Bioorg Chem. 2021, 105177. Bioorg Chem. 2024 Mar 5:146:107261. Biosci Rep. 2019 May 21;39(5):BSR20182137. Cancer Cell Int. 2024 May 31;24(1):192. Cancer Cell. 2024 Apr 8;42(4):682-700.e12. Cell Biol Toxicol. 2021 Jul 20. Cell Cycle. 2022 Nov 12;1-18. Cytotechnology. 02 October 2021. Drug Chem Toxicol. 2023 Feb 23;1-9. Eur J Med Chem. 2022 Jan 28;231:114151. Fitoterapia. 2021 Jun 30;104984. Food Funct. 2022 May 10;13(9):5089-5101. Free Radic Biol Med. 2020 Feb 1;147:220-230. Front Cell Dev Biol. 2022 Feb 10:10:810327. Genes. 2024 Sep 13. Int J Biol Macromol. 2023 Nov 17:127779. iScience. 2024 Feb 5;27(3):109111. IUBMB Life. 2024 Jul 16. J Biol Chem. 2023 Nov 15:105462. J Cell Mol Med. 2020 Apr;24(7):4212-4222. J Cell Physiol. 2024 Feb 3. J Mol Histol. 2024 May 27. J Nat Prod. 2022 Jul 7. J Neurosci Res. 2019 Dec;97(12):1689-1705. J Pharmacol Toxicol Methods. Nov-Dec 2020;106:106913. J Sex Med. 2018 Feb;15(2):136-147. Mol Biol Rep. 2024 Mar 14;51(1):421. Mol Med Rep. 2019 Dec; 20(6): 4933–4942. Nat Immunol. 2022 Dec 21. Nigerian Journal of Scientific Research. 18 (3): 2019. Oxid Med Cell Longev. 2022 Jan 27;2022:7502632. Redox Biol. 2022 Aug;54:102392. Research Square Print. 2022 Aug. Sci China Life Sci. 2018 Oct;61(10):1151-1167. Environ Toxicol. 2021 Apr;36(4):520-529. FASEB J. 2020 Sep;34(9):11474-11487. Hematol Oncol. 2024 Jul;42(4):e3295. J Afr Ass Physiol Sci. 7(1): 30-37, July 2019. Mil Med Res. 2020 Nov 1;7(1):52.
Smiles	OC([C@@]1([H])[C@H](CO)O)=C(O)C(O1)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	L-Ascorbate, Vitamin C
Versandbedingung	Raumtemperatur
Lieferbar
Manufacturer - Type	Natural Products
Manufacturer - Applications	Metabolism-sugar/lipid metabolism
Manufacturer - Targets	Apoptosis; Calcium Channel; Endogenous Metabolite; Reactive Oxygen Species
Shipping Temperature	Room Temperature
Storage Conditions	RT, protect from light
Molecular Weight	176.12
Product Description	L-Ascorbic acid (L-Ascorbate), an electron donor, is an endogenous antioxidant agent. L-Ascorbic acid inhibits selectively Cav3.2 channels with an IC50 of 6.5 μM. L-Ascorbic acid is also a collagen deposition enhancer and an elastogenesis inhibitor[1][2][3]. L-Ascorbic acid exhibits anti-cancer effects through the generation of reactive oxygen species (ROS) and selective damage to cancer cells[4].
Manufacturer - Research Area	Cancer; Metabolic Disease; Neurological Disease
Solubility	DMSO : 100 mg/mL (ultrasonic)\|H2O : ≥ 100 mg/mL
Manufacturer - Pathway	Apoptosis; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB
Isoform	Microbial Metabolite; T-type calcium channel
Clinical information	Launched

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkdatenblatt anfordern

HY-B0166-500mg-safety-datasheet.pdf